These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 21990040)

  • 1. Choroid plexus tumors; management, outcome, and association with the Li-Fraumeni syndrome: the Children's Hospital Los Angeles (CHLA) experience, 1991-2010.
    Gozali AE; Britt B; Shane L; Gonzalez I; Gilles F; McComb JG; Krieger MD; Lavey RS; Shlien A; Villablanca JG; Erdreich-Epstein A; Dhall G; Jubran R; Tabori U; Malkin D; Finlay JL
    Pediatr Blood Cancer; 2012 Jun; 58(6):905-9. PubMed ID: 21990040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TP53 alterations determine clinical subgroups and survival of patients with choroid plexus tumors.
    Tabori U; Shlien A; Baskin B; Levitt S; Ray P; Alon N; Hawkins C; Bouffet E; Pienkowska M; Lafay-Cousin L; Gozali A; Zhukova N; Shane L; Gonzalez I; Finlay J; Malkin D
    J Clin Oncol; 2010 Apr; 28(12):1995-2001. PubMed ID: 20308654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of germline TP53 mutations and history of Li-Fraumeni syndrome in families with childhood adrenocortical tumors, choroid plexus tumors, and rhabdomyosarcoma: a population-based survey.
    Magnusson S; Gisselsson D; Wiebe T; Kristoffersson U; Borg Å; Olsson H
    Pediatr Blood Cancer; 2012 Nov; 59(5):846-53. PubMed ID: 22653678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Li-Fraumeni and Li-Fraumeni-like syndrome among children diagnosed with pediatric cancer in Southern Brazil.
    Giacomazzi J; Selistre SG; Rossi C; Alemar B; Santos-Silva P; Pereira FS; Netto CB; Cossio SL; Roth DE; Brunetto AL; Zagonel-Oliveira M; Martel-Planche G; Goldim JR; Hainaut P; Camey SA; Ashton-Prolla P
    Cancer; 2013 Dec; 119(24):4341-9. PubMed ID: 24122735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiation therapy for choroid plexus carcinoma patients with Li-Fraumeni syndrome: advantageous or detrimental?
    Bahar M; Kordes U; Tekautz T; Wolff J
    Anticancer Res; 2015 May; 35(5):3013-7. PubMed ID: 25964589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between choroid plexus carcinoma and Li-Fraumeni syndrome: implications of TP53 mutations and management strategies-a case-based narrative review.
    Mallik D; Gopal S; Scalia G; Umana G; Rajeswarie RT; Chaurasia B
    Childs Nerv Syst; 2024 Jun; 40(6):1699-1705. PubMed ID: 38316675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes.
    Ruijs MW; Verhoef S; Rookus MA; Pruntel R; van der Hout AH; Hogervorst FB; Kluijt I; Sijmons RH; Aalfs CM; Wagner A; Ausems MG; Hoogerbrugge N; van Asperen CJ; Gomez Garcia EB; Meijers-Heijboer H; Ten Kate LP; Menko FH; van 't Veer LJ
    J Med Genet; 2010 Jun; 47(6):421-8. PubMed ID: 20522432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High frequency of de novo mutations in Li-Fraumeni syndrome.
    Gonzalez KD; Buzin CH; Noltner KA; Gu D; Li W; Malkin D; Sommer SS
    J Med Genet; 2009 Oct; 46(10):689-93. PubMed ID: 19556618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond Li Fraumeni Syndrome: clinical characteristics of families with p53 germline mutations.
    Gonzalez KD; Noltner KA; Buzin CH; Gu D; Wen-Fong CY; Nguyen VQ; Han JH; Lowstuter K; Longmate J; Sommer SS; Weitzel JN
    J Clin Oncol; 2009 Mar; 27(8):1250-6. PubMed ID: 19204208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case Report : Li-Fraumeni Syndrome with Central Nervous System Tumors in Two Siblings.
    Fang Z; Su Y; Sun H; Ge M; Qi Z; Hao C; Qian S; Ma X
    BMC Pediatr; 2021 Dec; 21(1):588. PubMed ID: 34961499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel oncogene amplifications in tumors from a family with Li-Fraumeni syndrome.
    Rieber J; Remke M; Hartmann C; Korshunov A; Burkhardt B; Sturm D; Mechtersheimer G; Wittmann A; Greil J; Blattmann C; Witt O; Behnisch W; Halatsch ME; Orakcioglu B; von Deimling A; Lichter P; Kulozik A; Pfister S
    Genes Chromosomes Cancer; 2009 Jul; 48(7):558-68. PubMed ID: 19378321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel TP53 germline mutation in a family with a history of multiple malignancies: case report and review of the literature.
    Agarwalla PK; Dunn IF; Turner CD; Ligon KL; Schneider KA; Smith ER
    Pediatr Neurosurg; 2008; 44(6):501-8. PubMed ID: 19127094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant triton tumor in a patient with Li-Fraumeni syndrome and a novel TP53 mutation.
    Chao MM; Levine JE; Ruiz RE; Kohlmann WK; Bower MA; Petty EM; Mody RJ
    Pediatr Blood Cancer; 2007 Dec; 49(7):1000-4. PubMed ID: 16333835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical spectrum of Li-Fraumeni syndrome/Li-Fraumeni-like syndrome in Brazilian individuals with the TP53 p.R337H mutation.
    Ferreira AM; Brondani VB; Helena VP; Charchar HLS; Zerbini MCN; Leite LAS; Hoff AO; Latronico AC; Mendonca BB; Diz MDPE; de Almeida MQ; Fragoso MCBV
    J Steroid Biochem Mol Biol; 2019 Jun; 190():250-255. PubMed ID: 30974190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer phenotype correlates with constitutional TP53 genotype in families with the Li-Fraumeni syndrome.
    Birch JM; Blair V; Kelsey AM; Evans DG; Harris M; Tricker KJ; Varley JM
    Oncogene; 1998 Sep; 17(9):1061-8. PubMed ID: 9764816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue-specific expression of SV40 in tumors associated with the Li-Fraumeni syndrome.
    Malkin D; Chilton-MacNeill S; Meister LA; Sexsmith E; Diller L; Garcea RL
    Oncogene; 2001 Jul; 20(33):4441-9. PubMed ID: 11494139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Li-Fraumeni syndrome: update, new data and guidelines for clinical management].
    Frebourg T; Abel A; Bonaiti-Pellie C; Brugières L; Berthet P; Bressac-de Paillerets B; Chevrier A; Chompret A; Cohen-Haguenauer O; Delattre O; Feingold J; Feunteun J; Frappaz D; Fricker JP; Gesta P; Jonveaux P; Kalifa C; Lasset C; Leheup B; Limacher JM; Longy M; Nogues C; Oppenheim D; Sommelet D; Soubrier F; Stoll C; Stoppa-Lyonnet D; Tristant H
    Bull Cancer; 2001 Jun; 88(6):581-7. PubMed ID: 11459705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germline TP53 mutations and Li-Fraumeni syndrome.
    Varley JM
    Hum Mutat; 2003 Mar; 21(3):313-20. PubMed ID: 12619118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risks of first and subsequent cancers among TP53 mutation carriers in the National Cancer Institute Li-Fraumeni syndrome cohort.
    Mai PL; Best AF; Peters JA; DeCastro RM; Khincha PP; Loud JT; Bremer RC; Rosenberg PS; Savage SA
    Cancer; 2016 Dec; 122(23):3673-3681. PubMed ID: 27496084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype.
    Olivier M; Goldgar DE; Sodha N; Ohgaki H; Kleihues P; Hainaut P; Eeles RA
    Cancer Res; 2003 Oct; 63(20):6643-50. PubMed ID: 14583457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.